Income Statement (TTM)
Coherus Oncology, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 489 | 476 | 443 | 395 | 364 | 327 | 304 | 276 | 239 | 211 | 183 | 182 | 211 | 257 | 227 | 179 | 175 | 267 | 272 | 272 |
| Change (%) | -2.75 | -6.97 | -10.85 | -7.87 | -10.19 | -7.02 | -9.05 | -13.43 | -11.72 | -13.12 | -0.78 | 16.02 | 21.88 | -11.71 | -21.32 | -2.12 | 52.63 | 1.98 | -0.02 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | -25 | 38 | 38 | 45 | 52 | 58 | 59 | 54 | 73 | 70 | 78 | 91 | 89 | 159 | 144 | 121 | 109 | 118 | 119 | 120 |
| Change (%) | -248.06 | 1.74 | 17.11 | 15.78 | 10.84 | 3.23 | -9.12 | 35.45 | -4.24 | 10.71 | 17.49 | -2.78 | 79.39 | -9.71 | -16.05 | -9.93 | 8.29 | 1.03 | 1.34 | |
| % of Revenue | -5.20 | 7.92 | 8.66 | 11.37 | 14.29 | 17.64 | 19.58 | 19.57 | 30.61 | 33.21 | 42.31 | 50.11 | 41.99 | 61.81 | 63.21 | 67.44 | 62.07 | 44.03 | 43.62 | 44.21 |
| Gross Operating Profit | 515 | 438 | 404 | 350 | 312 | 269 | 244 | 222 | 166 | 141 | 106 | 91 | 122 | 98 | 84 | 58 | 66 | 149 | 153 | 152 |
| Change (%) | -14.87 | -7.71 | -13.50 | -10.90 | -13.70 | -9.21 | -9.04 | -25.32 | -15.02 | -24.96 | -14.19 | 34.90 | -19.76 | -14.95 | -30.37 | 14.04 | 125.19 | 2.73 | -1.06 | |
| % of Revenue | 105.20 | 92.08 | 91.34 | 88.63 | 85.71 | 82.36 | 80.42 | 80.43 | 69.39 | 66.79 | 57.69 | 49.89 | 58.01 | 38.19 | 36.79 | 32.56 | 37.93 | 55.97 | 56.38 | 55.79 |
| SG&A | 137 | 139 | 143 | 149 | 157 | 170 | 179 | 190 | 195 | 198 | 195 | 193 | 192 | 186 | 170 | 148 | 139 | 150 | 147 | 145 |
| Change (%) | 1.18 | 2.91 | 4.40 | 5.31 | 7.85 | 5.52 | 6.10 | 2.58 | 1.83 | -1.61 | -1.30 | -0.57 | -3.14 | -8.58 | -12.51 | -6.05 | 7.85 | -2.40 | -1.01 | |
| % of Revenue | 28.09 | 29.23 | 32.33 | 37.86 | 43.28 | 51.97 | 58.98 | 68.81 | 81.53 | 94.05 | 106.50 | 105.95 | 90.79 | 72.16 | 74.72 | 83.08 | 79.75 | 56.35 | 53.93 | 53.40 |
| R&D | 192 | 143 | 310 | 342 | 357 | 363 | 246 | 229 | 221 | 199 | 151 | 129 | 112 | 106 | 100 | 101 | 93 | 93 | 89 | 95 |
| Change (%) | -25.73 | 117.10 | 10.26 | 4.46 | 1.72 | -32.32 | -6.66 | -3.61 | -9.83 | -24.46 | -14.57 | -12.87 | -5.58 | -5.41 | 0.93 | -7.49 | -0.14 | -4.36 | 6.39 | |
| % of Revenue | 39.29 | 30.00 | 70.01 | 86.59 | 98.18 | 111.19 | 80.93 | 83.06 | 92.49 | 94.46 | 82.13 | 70.72 | 53.11 | 41.14 | 44.08 | 56.54 | 53.44 | 34.96 | 32.79 | 34.89 |
| OpEx | 304 | 320 | 491 | 536 | 566 | 590 | 484 | 473 | 489 | 468 | 423 | 413 | 392 | 450 | 413 | 370 | 342 | 361 | 355 | 361 |
| Change (%) | 5.02 | 53.79 | 9.09 | 5.64 | 4.26 | -17.98 | -2.24 | 3.33 | -4.35 | -9.50 | -2.58 | -4.90 | 14.80 | -8.23 | -10.48 | -7.71 | 5.80 | -1.79 | 1.64 | |
| % of Revenue | 62.18 | 67.15 | 111.00 | 135.83 | 155.74 | 180.80 | 159.49 | 171.44 | 204.63 | 221.72 | 230.94 | 226.77 | 185.89 | 175.10 | 182.00 | 207.07 | 195.26 | 135.35 | 130.35 | 132.50 |
| Operating Income | 185 | 156 | -49 | -141 | -203 | -264 | -181 | -197 | -250 | -257 | -240 | -231 | -181 | -193 | -186 | -191 | -167 | -94 | -83 | -88 |
| Change (%) | -15.52 | -131.15 | 190.32 | 43.36 | 30.18 | -31.54 | 9.21 | 26.80 | 2.70 | -6.53 | -3.94 | -21.39 | 6.57 | -3.60 | 2.73 | -12.92 | -43.36 | -12.45 | 7.09 | |
| % of Revenue | 37.82 | 32.85 | -11.00 | -35.83 | -55.74 | -80.80 | -59.49 | -71.44 | -104.63 | -121.72 | -130.94 | -126.77 | -85.89 | -75.10 | -82.00 | -107.07 | -95.26 | -35.35 | -30.35 | -32.50 |
| Interest Expense | -20 | -21 | -22 | -23 | -23 | -23 | -26 | -27 | -29 | -32 | -33 | -37 | -39 | -41 | -34 | -28 | -23 | -27 | -26 | -24 |
| Change (%) | 5.95 | 5.75 | 1.51 | 0.51 | 0.53 | 14.46 | 3.17 | 6.52 | 12.44 | 2.29 | 10.12 | 7.46 | 3.14 | -16.26 | -17.32 | -17.48 | 17.26 | -3.56 | -6.82 | |
| % of Revenue | -4.08 | -4.45 | -5.06 | -5.76 | -6.28 | -7.03 | -8.66 | -9.82 | -12.08 | -15.39 | -18.12 | -20.11 | -18.62 | -15.76 | -14.95 | -15.71 | -13.24 | -10.17 | -9.62 | -8.97 |
| Net Income | 162 | 132 | -76 | -165 | -232 | -287 | -210 | -230 | -279 | -292 | -271 | -264 | -217 | -238 | -59 | -29 | -0 | 29 | -131 | 180 |
| Change (%) | -18.25 | -157.68 | 116.59 | 40.23 | 23.93 | -26.77 | 9.63 | 20.88 | 4.72 | -6.98 | -2.68 | -17.80 | 9.57 | -75.08 | -50.51 | -98.47 | -6,434.89 | -559.32 | -237.28 | |
| % of Revenue | 33.06 | 27.79 | -17.23 | -41.86 | -63.71 | -87.92 | -69.24 | -83.47 | -116.54 | -138.24 | -148.01 | -145.18 | -102.86 | -92.48 | -26.10 | -16.42 | -0.26 | 10.68 | -48.09 | 66.03 |
Source: Capital IQ
